The integration of artificial intelligence (AI) with various diagnostic nanosensors has opened up new horizons in clinics recently. AI technology offers enhanced sensitivity, accuracy, specificity, and real-time analysis for disease diagnostics. This review focuses on the recent advances in AI-assisted nanosensors for the diagnosis of different diseases in clinical applications. Critical roles of AI in sensor design, optimization, signal processing, and clinical decision support are highlighted. Furthermore, challenges such as limited datasets, regulatory hurdles, and data privacy are discussed, along with future opportunities. This review aims to provide a comprehensive introduction and perspectives on how AI-driven nanosensors are transforming clinical diagnostics and shaping the future of precise medicine.
1 August 2021 in Sensors and Actuators B: Chemical
Folate (vitamin B9) plays an important role in cell division and tissue growth by participating in the amino acid metabolism and nucleotide metabolism. Folate deficiency among pregnant women and children is common around the world, particularly in developing countries. Accurate folate analysis is critical for quality control in pharmaceutical and food products. This review briefly introduces the physiochemical properties, folate deficiency and food fortification of synthetic and natural folates, and the emphases are focused on the progress of sample pretreatment and analysis methods of these compounds in pharmaceuticals and foods in the last decade.
Direct antibody labeling is essential for immunoassays, multiplexed imaging, and biosensing; however, current methods are often time-consuming, restricted by antibody source, risk compromising protein performance, or vary with multiple steps. We introduce multiplex in situ tagging (MIST) Linker, a rapid and Fc-site-specific labeling tool that conjugates fluorophores or DNA oligonucleotides to antibodies from diverse commercial sources in as fast as 10 min using minimal starting material. MIST Linker achieves >90% cleavage upon UV exposure, facilitating rapid cyclic imaging on a single specimen. Validated across multiple species and sources, the platform outperforms conventional two-step immunofluorescence and immunohistochemistry in various tissues and cell lines. By enabling the rapid, cost-effective customization of antibody panels, MIST Linker significantly lowers the barrier to accessing antibody–DNA conjugates for spatial biology. When integrated with the spatial MIST platform and MIST-Explorer, it enables high-plex, single-cell spatial proteomics at high signal-to-noise ratios in human clinical biopsies, mouse specimens and cell lines. This toolkit provides an efficient, accessible solution for high-resolution spatial mapping, allowing for the in-depth analysis of cell subpopulations, biomarker distributions, and signaling events in complex biological specimens. Thus, MIST Linker offers a versatile, accessible, and scalable solution for antibody-labeling-based research and clinical diagnosis.